Taiwan study tracks best biologic for psoriasis

NCT ID NCT04818385

Completed Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study followed 240 adults in Taiwan with moderate-to-severe plaque psoriasis to see how well risankizumab works compared to other biologics in real-world settings. Participants received their prescribed treatment and were monitored for about 2 years. The main goal was to measure how many achieved at least 90% clearer skin (PASI 90).

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: risankizumab and other biologics
What this could lead to: If successful, this study could provide real-world evidence on which biologic works best for psoriasis patients in Taiwan, helping doctors choose more effective treatments.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by patient differences. It does not test a new drug or prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Locations

China Medical University Hospital /ID# 229961

Taichung, 40447, Taiwan
Hualien Tzu Chi Hospital /ID# 238431

Hualien City, 97002, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 230016

Kaohsiung City, 807, Taiwan
Linkou Chang Gung Memorial Hospital /ID# 253775

Taoyuan City, 333, Taiwan
National Cheng Kung University Hospital /ID# 253776

Tainan, 704, Taiwan
National Taiwan University Hospital - Hsinchu branch /ID# 238432

Hsinchu, 30059, Taiwan
National Taiwan University Hospital /ID# 230017

Taipei City, Taipei, 100, Taiwan
Taipei Medical University Hospital /ID# 230018

Taipei, 11031, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.